Annals of Internal Medicine DOI:10.7326/ANNALS-25-00860 Abstract Glucagon-Like Peptide-1 Receptor Agonists and Risk for Ischemic Optic Neuropathy: A Target Trial Emulation Background: There are few data evaluating the association between glucagon-like peptide-1 receptor agonists (GLP-1RAs) and nonarteritic anterior ischemic optic neuropathy (NAION), which constitutes approximately 75% of ischemic optic neuropathy (ION) cases in adults
These facts led to the search for and design of GST inhibitors, including their synthetic analogues and glutathione conjugates, however, most of the existing inhibitors are either too toxic to be used in vivo or are effective only in vitro [14, 15]
Topamax (topiramate) is an antiepileptic medication with a more complex and not fully elucidated mechanism of action
"Novo Nordisk is addressing this issue through education, advocacy, and legal action against businesses that mislead Americans and jeopardize their health with unsafe and unapproved knockoffs
doi: 10.3390/nu8070405 213 YuanS.CaiZ.LuanX.WangH.ZhongY.DengL.et al
10.3109/08923970903279991 65 KimS.-H.JunC.-D.SukK.ChoiB.-J.LimH.ParkS.et al (2006)